PPP6C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.325830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.927600E-01
Normal-vs-Stage2
6.511800E-02
Normal-vs-Stage3
4.874300E-02
Normal-vs-Stage4
5.008000E-01
Stage1-vs-Stage2
3.980800E-01
Stage1-vs-Stage3
1.212010E-01
Stage1-vs-Stage4
7.964800E-01
Stage2-vs-Stage3
1.976850E-01
Stage2-vs-Stage4
3.061200E-01
Stage3-vs-Stage4
1.424950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.314590E-01
Normal-vs-AfricanAmerican
3.352400E-01
Normal-vs-Asian
1.320200E-01
Caucasian-vs-AfricanAmerican
7.689400E-01
Caucasian-vs-Asian
6.071200E-01
AfricanAmerican-vs-Asian
6.051600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.180300E-02
Normal-vs-Female
2.081800E-01
Male-vs-Female
1.994560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.518800E-01
Normal-vs-Age(41-60Yrs)
3.974600E-01
Normal-vs-Age(61-80Yrs)
7.290000E-02
Normal-vs-Age(81-100Yrs)
1.399810E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.187400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.085800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.670600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.262500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.337800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.303500E-02
Normal-vs-Daily Drinker
5.845900E-02
Normal-vs-Weekly Drinker
4.231800E-02
Normal-vs-Occasional Drinker
2.203600E-01
Normal-vs-Social Drinker
5.427600E-01
Non Drinker-vs-Daily Drinker
5.389200E-01
Non Drinker-vs-Weekly Drinker
9.033800E-01
Non Drinker-vs-Occasional Drinker
1.959420E-01
Non Drinker-vs-Social Drinker
1.772620E-01
Daily Drinker-vs-Weekly Drinker
5.293600E-01
Daily Drinker-vs-Occasional Drinker
4.641800E-01
Daily Drinker-vs-Social Drinker
3.131000E-01
Weekly Drinker-vs-Occasional Drinker
2.507400E-01
Weekly Drinker-vs-Social Drinker
1.800040E-01
Occasional Drinker-vs-Social Drinker
6.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.418040E-01
Normal-vs-Grade 2
2.264100E-02
Normal-vs-Grade 3
2.658500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.108400E-01
Grade 1-vs-Grade 3
2.547800E-01
Grade 1-vs-Grade 4
1.418040E-01
Grade 2-vs-Grade 3
4.877600E-01
Grade 2-vs-Grade 4
2.264100E-02
Grade 3-vs-Grade 4
2.658500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.240200E-02
Normal-vs-NonDiabetic
1.368430E-01
Diabetic-vs-NonDiabetic
3.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.362400E-03
Normal-vs-NoPancreatitis
1.336440E-01
Pancreatitis-vs-NoPancreatitis
2.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.331400E-01
Normal-vs-N1
6.274400E-02
N0-vs-N1
3.569400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.421900E-02
Normal-vs-TP53-NonMutant
4.281400E-01
TP53-Mutant-vs-TP53-NonMutant
7.543800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
